Total Payments
$1,064
2023 Payments
$20.73
Companies
11
Transactions
54
Medicare Patients
8,100
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$1,064 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,064 | 54 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $289.12 | 20 | $0 (2020) |
| Boston Scientific Corporation | $278.72 | 12 | $0 (2023) |
| Abbott Laboratories | $172.58 | 5 | $0 (2020) |
| DePuy Synthes Sales Inc. | $91.80 | 4 | $0 (2020) |
| Novo Nordisk Inc | $70.06 | 5 | $0 (2022) |
| SI-BONE, INC. | $38.26 | 2 | $0 (2021) |
| Lilly USA, LLC | $34.01 | 2 | $0 (2020) |
| Nevro Corp. | $27.59 | 1 | $0 (2017) |
| Allergan Inc. | $23.49 | 1 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $19.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $20.73 | 1 | Boston Scientific Corporation ($20.73) |
| 2022 | $28.44 | 2 | Boston Scientific Corporation ($15.63) |
| 2021 | $18.39 | 1 | SI-BONE, INC. ($18.39) |
| 2020 | $176.73 | 7 | Boston Scientific Corporation ($79.11) |
| 2019 | $126.03 | 8 | Lundbeck LLC ($55.80) |
| 2018 | $239.56 | 14 | BOSTON SCIENTIFIC CORPORATION ($89.45) |
| 2017 | $453.94 | 21 | Lundbeck LLC ($166.75) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: General - Pain Management_NMD | ||||||
| 03/30/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Diabetes | ||||||
| 03/16/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/14/2021 | SI-BONE, INC. | IFUSE IMPLANT (Device) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: SACROILIAC JOINT DYSFUNCTION | ||||||
| 12/15/2020 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Sports Early Intervention | ||||||
| 08/06/2020 | Abbott Laboratories | Neuromodulation Dspsbls and Accs (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/05/2020 | Boston Scientific Corporation | GENERAL - (Device) | Food and Beverage | In-kind items and services | $66.89 | General |
| Category: GENERAL | ||||||
| 02/14/2020 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Sports Early Intervention | ||||||
| 02/05/2020 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: PSYCHIATRY | ||||||
| 01/13/2020 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 01/10/2020 | Boston Scientific Corporation | GENERAL - PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/25/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Immunology | ||||||
| 07/08/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/25/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: Opioid Analgesic | ||||||
| 04/18/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/03/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.68 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2019 | Lundbeck LLC | BRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: PSYCHIATRY | ||||||
| 01/09/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2018 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Sports Early Intervention | ||||||
| 12/05/2018 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/29/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Diabetes | ||||||
| 10/04/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/17/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,043 | 3,174 | $2.1M | $265,905 |
| 2022 | 24 | 1,837 | 3,307 | $1.7M | $249,190 |
| 2021 | 30 | 2,357 | 4,060 | $1.9M | $305,766 |
| 2020 | 27 | 1,863 | 3,387 | $1.4M | $219,148 |
Total Patients
8,100
Total Services
13,928
Medicare Billing
$1.0M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 547 | $356,630 | $59,676 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 295 | 531 | $269,290 | $40,357 | 15.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 157 | 453 | $179,645 | $29,230 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 193 | 193 | $177,560 | $28,022 | 15.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 180 | 191 | $138,100 | $22,089 | 16.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 81 | 94 | $164,713 | $9,768 | 5.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 96 | 96 | $71,820 | $8,974 | 12.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 61 | 87 | $54,810 | $7,838 | 14.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 100 | $53,500 | $7,225 | 13.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 32 | 41 | $110,220 | $7,087 | 6.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 50 | 62 | $109,223 | $6,778 | 6.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 58 | 119 | $62,635 | $5,371 | 8.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 41 | $43,665 | $4,844 | 11.1% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 21 | 21 | $37,590 | $4,677 | 12.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 51 | 79 | $79,600 | $4,414 | 5.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 77 | 88 | $57,695 | $4,237 | 7.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 33 | 33 | $32,835 | $4,046 | 12.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 50 | 62 | $52,315 | $3,823 | 7.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 32 | 42 | $34,518 | $2,262 | 6.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 19 | 21 | $27,000 | $1,793 | 6.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 16 | 18 | $16,560 | $1,721 | 10.4% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 23 | 23 | $7,405 | $830.35 | 11.2% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 14 | 16 | $5,840 | $668.62 | 11.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 101 | 216 | $1,170 | $173.81 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 572 | $366,545 | $66,808 | 18.2% |
About Dr. Michael Robinson, MD
Dr. Michael Robinson, MD is a Physical Medicine & Rehabilitation healthcare provider based in Airmont, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699768069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Robinson, MD has received a total of $1,064 in payments from pharmaceutical and medical device companies, with $20.73 received in 2023. These payments were reported across 54 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,064).
As a Medicare-enrolled provider, Robinson has provided services to 8,100 Medicare beneficiaries, totaling 13,928 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Interventional Pain Medicine, Pain Medicine
- Location Airmont, NY
- Active Since 08/31/2005
- Last Updated 07/25/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1699768069
Products in Payments
- REXULTI (Drug) $159.99
- SCS IPGs (Device) $121.44
- TRINTELLIX (Drug) $102.93
- GENERAL PAIN MANAGEMENT (Device) $89.45
- GENERAL - (Device) $66.89
- Tresiba (Drug) $57.25
- MONOVISC (Device) $47.54
- ORTHOVISC (Device) $44.26
- GENERAL - PAIN MANAGEMENT (Device) $37.79
- GENERAL PAIN MANAGEMENT (Device) $34.02
- TALTZ (Drug) $34.01
- Senza Spinal Cord Stimulation System (Device) $27.59
- BRINTELLIX (Drug) $26.20
- BOTOX CHRONIC MIGRAINE (Drug) $23.49
- Neuromodulation Dspsbls and Accs (Device) $21.89
- iFuse Implant (Device) $19.87
- XIAFLEX (Biological) $19.37
- XTAMPZA (Drug) $18.82
- IFUSE IMPLANT (Device) $18.39
- Proclaim Family of SCS IPGs (Device) $16.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.